3 studies found for:    22634621 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Conditions: Diabetes;   Type 1 Diabetes
Intervention: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP)
2 Suspended A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Alpha 1-Antitrypsin;   Biological: Alpha-1 Antitrypsin
3 Completed Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Alpha-1 Antitrypsin 40mg (AAT, Glassia®);   Drug: Alpha-1 Antitrypsin 60mg (AAT, Glassia®);   Drug: Alpha-1 Antitrypsin 80mg (AAT, Glassia®)

Indicates status has not been verified in more than two years